AllSquare Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-355
Closed -$7K 385
2017
Q3
$7K Buy
+355
New +$7.1K 0.01% 282
2017
Q2
Sell
-355
Closed -$7K 188
2017
Q1
$7K Hold
355
0.01% 275
2016
Q4
$7K Hold
355
0.01% 249
2016
Q3
$7K Hold
355
0.01% 234
2016
Q2
$8K Hold
355
0.01% 214
2016
Q1
$8K Buy
+355
New +$7.94K 0.01% 215

Other funds holding BTAL

AllSquare Wealth Management's BTAL Position: Q4 2017 in Review

AllSquare Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2017, closing a stake of 355 shares — an estimated $7K sold.

AllSquare Wealth Management first reported a position in BTAL in Q1 2016 and held it in 6 quarters. The position peaked at $8K in Q2 2016. 5 funds tracked by Wall St. Rank hold BTAL as of Q4 2017.

  • AllSquare Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2017 after selling out during the quarter.
  • AllSquare Wealth Management sold 355 AGF US Market Neutral Anti-Beta Fund shares in Q4 2017, an estimated $7K.
  • AllSquare Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2016 and held it in 6 quarters.
  • AllSquare Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $8K in Q2 2016.
  • 5 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2017.

Based on AllSquare Wealth Management's 13F filing for Q4 2017, filed 13 Feb 2018.